title: Autoimmune haemolytic anaemia occurring during ibrutinib therapy for chronic lymphocytic leukaemia--response to Rider et al.
authors.affiliation: Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA. danilov@ohsu.edu.
authors.forename: Alexey V
authors.initials: AV
authors.lastname: Danilov
mesh_terms: D000744:Anemia, Hemolytic, Autoimmune / Q000188:drug therapy*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008297:Male; D011720:Pyrazoles / Q000008:administration & dosage*; D011743:Pyrimidines / Q000008:administration & dosage*
chemical_list: D011720:Pyrazoles; D011743:Pyrimidines
keywords: autoimmune haemolytic anaemia; chronic lymphocytic leukaemia; ibrutinib